OR WAIT null SECS
March 20, 2020
Emergent BioSolutions will help develop and manufacture an oral vaccine candidate and will develop plasma-based antibody therapeutics.
March 19, 2020
Belgian-based bioprocessing provider, Univercells, has launched a CDMO, Exothera, that will support developers of cell and gene therapies through process development and production of viral vectors.
March 02, 2020
The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.
February 06, 2020
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
February 05, 2020
Catalent builds on its investment in cell and gene therapy development and manufacturing with the acquisition of MaSTherCell Global.
February 01, 2020
The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.
January 16, 2020
Karen Flynn rejoins Catalent as president of biologics operations; regional presidents named for US and Europe.
December 17, 2019
The acquisition expands Charles River’s scientific capabilities in cell therapy development.
November 22, 2019
New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.